The country’s first corona virus vaccine, which is developed in by ICMR in partnership with Hyderabad-based Bharat Biotech could be released by August 15 for the public use.
A major development from Indian Council of Medical Research (ICMR), the apex body for the medical research in the country, on Thursday said that it will launch the corona virus vaccine COVAXIN™ for the public use by August 15.
Hyderabad-based Bharat Biotech successfully developed COVAXIN™ in collaboration with the ICMR and National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech for the effort.
In a letter written to Bharat Biotech and principal investigators of medical colleges, ICMR Chief Balram Bhargava has asked for fast-tracking of the indigenous vaccine with an aim to launch by August 15.
“This is the first indigenous vaccine being developed by India and is one of the top priority projects which is being monitored at the topmost level of the Government. The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of virology. Pune- ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine,” the letter read.
In a major development, the Indian Council of Medical Research (ICMR), the apex body for the medical research in the country, on Thursday said that it will launch the corona virus vaccine COVAXIN™ for the public use by August 15.
The country’s first corona virus vaccine, which is developed in by ICMR in partnership with Hyderabad-based Bharat Biotech could be released by August 15 for the public use.
Hyderabad-based Bharat Biotech successfully developed COVAXIN™ in collaboration with the ICMR and National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech for the effort.
In a letter written to Bharat Biotech and principal investigators of medical colleges, ICMR Chief Balram Bhargava has asked for fast-tracking of the indigenous vaccine with an aim to launch by August 15.
“This is the first indigenous vaccine being developed by India and is one of the top priority projects which is being monitored at the topmost level of the Government. The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of virology. Pune- ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine,” the letter read.
